secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001193125-23-233693
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO August Moretti retires; Uneek Mehra appointed as CFO effective Sept 11, 2023
--------------------------------------------------------------------------------

- August J. Moretti retired as CFO effective Sept 11, 2023; will serve as Senior Business Advisor through 2023 then consultant through Dec 2024 at $18k/month.
- Uneek Mehra appointed CFO, Principal Financial and Accounting Officer; base salary $510k, target bonus 45%, option grant of 229,634 shares.
- Mehra previously served as CFO at Myovant Sciences (Sept 2021-July 2023) and PACT Pharma.
- Sign-on bonus of $200k in two installments; severance includes 9 months base salary and COBRA reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523233693/0001193125-23-233693-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523233693/d387807d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-233693

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer